Zentalis Pharmaceuticals, Inc. (ZNTL) — Quantitative Stock Analysis

Quantitative analysis for Zentalis Pharmaceuticals, Inc. (ZNTL) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based return forecast, technical and fundamental signals, insider and institutional flow, and walk-forward validated accuracy.

Current Q-Score verdict: Hold (41.0) (grade C). Gem alpha score: 62.0. 27 signals analyzed (23 differentiated alt-data).

Key Quantitative Facts

What StoQuant measures for ZNTL

Access the full research

Detailed interactive charts, factor decomposition, and forecast bands are available to signed-in members. Learn more or view pricing.